Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study.
Sekulic A, Migden MR, Basset-Seguin N, Garbe C, Gesierich A, Lao CD, Miller C, Mortier L, Murrell DF, Hamid O, Quevedo JF, Hou J, McKenna E, Dimier N, Williams S, Schadendorf D, Hauschild A; ERIVANCE BCC Investigators.
Sekulic A, et al. Among authors: mckenna e.
BMC Cancer. 2017 May 16;17(1):332. doi: 10.1186/s12885-017-3286-5.
BMC Cancer. 2017.
PMID: 28511673
Free PMC article.
Clinical Trial.